| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 54 | 116 | 103 | 116 | 126 | 116 | 114 | 119 | 107 | 124 | 117 | 126 | 127 | 146 | 138 | 159 | 160 | 188 | 174 |
| Expenses | 38 | 62 | 54 | 58 | 66 | 62 | 63 | 68 | 65 | 72 | 69 | 72 | 73 | 82 | 82 | 92 | 95 | 107 | 102 |
| EBITDA | 16 | 54 | 49 | 59 | 60 | 54 | 51 | 51 | 43 | 52 | 48 | 54 | 54 | 64 | 55 | 66 | 65 | 81 | 72 |
| Operating Profit % | 27 % | 45 % | 46 % | 49 % | 46 % | 45 % | 43 % | 41 % | 38 % | 40 % | 39 % | 41 % | 40 % | 41 % | 38 % | 41 % | 39 % | 42 % | 40 % |
| Depreciation | 12 | 14 | 13 | 13 | 12 | 13 | 13 | 15 | 14 | 16 | 20 | 11 | 13 | 14 | 15 | 16 | 17 | 17 | 18 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Profit Before Tax | 1 | 36 | 33 | 43 | 44 | 38 | 34 | 31 | 24 | 31 | 22 | 37 | 36 | 45 | 35 | 44 | 42 | 57 | 47 |
| Tax | -1 | 9 | 8 | 11 | 11 | 10 | 8 | 8 | 6 | 8 | 6 | 9 | 9 | 11 | 9 | 10 | 10 | 15 | 11 |
| Net Profit | 2 | 27 | 25 | 32 | 33 | 28 | 26 | 24 | 18 | 24 | 17 | 28 | 26 | 34 | 26 | 34 | 32 | 42 | 35 |
| EPS in ₹ | 3.55 | 2.59 | 2.43 | 3.08 | 3.23 | 2.72 | 2.48 | 2.33 | 1.71 | 2.29 | 1.60 | 2.69 | 2.57 | 3.26 | 2.53 | 3.27 | 3.06 | 4.09 | 3.42 |
Vijaya Diagnostic Centre
1,016.90
+0.45
(0.04%)
Market Cap
10,436.39 Cr
EPS
11.62
PE Ratio
73.53
Dividend Yield
0.10 %
Industry
Healthcare Services52 Week High
1,275.00
52 Week low
596.05
PB Ratio
14.39
Debt to Equity
0.42
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from7 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 2,502.30 | 20,914.79 | 50.76 | 2,295.80 | 11.52 | 362 | 19.34 | 45.50 | |
| 1,016.90 | 10,436.39 | 73.53 | 568.60 | 20.11 | 120 | 35.77 | 50.92 | |
| 1,607.70 | 8,242.25 | 54.57 | 1,216.80 | 4.59 | 129 | 15.38 | 38.56 | |
| 689.75 | 3,655.11 | 41.81 | 581.30 | 8.63 | 70 | 29.25 | 38.13 | |
| 713.65 | 2,304.36 | 30.16 | 636.40 | 25.65 | 57 | 49.23 | 37.03 | |
| 1,779.95 | 1,527.69 | 31.47 | 86.70 | 25.47 | 32 | 58.82 | 45.49 | |
| 237.98 | 757.03 | 7.33 | 1,436.10 | 35.04 | 6 | -1,081.25 | 42.21 | |
| 283.60 | 201.40 | 17.55 | 63.00 | 248.07 | 7 | 133.33 | 48.26 | |
| 133.00 | 92.62 | 70.71 | 36.90 | 6.34 | 1 | 0.00 | 54.20 | |
| 82.17 | 84.60 | 100.21 | 13.60 | -8.11 | -3 | 142.86 | 70.11 |
Growth Rate
Revenue Growth
20.11 %
Net Income Growth
40.38 %
Cash Flow Change
11.35 %
ROE
16.29 %
ROCE
17.56 %
EBITDA Margin (Avg.)
2.58 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 234 | 301 | 482 | 541 | 714 | 853 | 983 |
| Fixed Assets | 119 | 151 | 272 | 268 | 371 | 524 | 742 |
| Current Assets | 103 | 138 | 186 | 239 | 270 | 276 | 211 |
| Capital Work in Progress | 3 | 3 | 10 | 9 | 34 | 28 | 9 |
| Investments | 73 | 69 | 55 | 28 | 54 | 139 | 109 |
| Other Assets | 39 | 78 | 146 | 236 | 255 | 163 | 123 |
| Total Liabilities | 234 | 301 | 482 | 541 | 714 | 853 | 983 |
| Current Liabilities | 40 | 50 | 59 | 44 | 66 | 66 | 73 |
| Non Current Liabilities | 33 | 40 | 150 | 138 | 178 | 241 | 250 |
| Total Equity | 161 | 211 | 274 | 359 | 470 | 547 | 660 |
| Reserve & Surplus | 155 | 204 | 270 | 355 | 458 | 535 | 647 |
| Share Capital | 5 | 5 | 5 | 5 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -44 | -7 | 46 | -49 | 4 | 13 | -2 |
| Investing Activities | -98 | -90 | -31 | -130 | -123 | -110 | -141 |
| Operating Activities | 62 | 91 | 106 | 130 | 158 | 165 | 183 |
| Financing Activities | -8 | -7 | -30 | -49 | -31 | -42 | -45 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 60.00 % | 54.78 % | 54.78 % | 54.78 % | 55.04 % | 55.01 % | 55.01 % | 55.01 % | 54.98 % | 54.90 % | 54.87 % | 54.06 % | 53.93 % | 53.91 % | 53.91 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 20.09 % | 20.08 % | 18.14 % | 17.54 % |
| DIIs | 0.00 % | 14.09 % | 13.30 % | 12.88 % | 12.76 % | 15.28 % | 14.23 % | 13.90 % | 19.03 % | 17.99 % | 19.55 % | 20.80 % | 21.49 % | 23.46 % | 24.63 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.45 % | 3.71 % | 3.82 % | 4.00 % | 4.97 % | 5.18 % | 5.13 % | 5.03 % | 5.06 % | 4.63 % | 4.38 % | 3.98 % | 3.94 % | 3.43 % |
| Others | 40.00 % | 25.68 % | 28.21 % | 28.52 % | 28.20 % | 24.74 % | 25.58 % | 25.96 % | 20.96 % | 22.05 % | 20.95 % | 0.67 % | 0.52 % | 0.55 % | 0.49 % |
| No of Share Holders | 7 | 2,34,724 | 82,139 | 79,021 | 77,229 | 76,985 | 79,059 | 76,532 | 73,850 | 72,795 | 66,204 | 66,724 | 62,415 | 62,258 | 60,952 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.16 | 0.1 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Integrated Filing (Financial)
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Unaudited Financial Results For Q3 FY2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Approval Of The Unaudited (Standalone And Consolidated) Financial Results Of The Company
Announcement under Regulation 30 (LODR)-Allotment
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Receipt Of Observation Letters From BSE Limited With No Adverse Observations And National Stock Exchange Of India Limited With No Objection For The Scheme Of Amalgamation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Allotment
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Investor Presentation
Board Meeting Outcome for Outcome Of The Board Meeting Held On Nov 7, 2024
Unaudited Financial Results For The Quarter And Half Year Ended Sep 30, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended September 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Newspaper Publication
Business Responsibility and Sustainability Reporting (BRSR)
Reg. 34 (1) Annual Report.
Notice For The 22Nd Annual General Meeting Of Vijaya Diagnostic Centre Limited
Announcement under Regulation 30 (LODR)-Newspaper Publication
Corporate Action - Record Date Fixed For Friday, 30Th August, 2024 For Dividend Payment
Intimation Of 22Nd Annual General Meeting (AGM), Record Date And Cut-Off Date For E-Voting & AGM.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Re-Appointment Of Secretarial Auditor For The FY 2024-2025
Company Filings to Exchanges
Technical Indicators
RSI(14)
Neutral 50.92
ATR(14)
Less Volatile 73.25
STOCH(9,6)
Neutral 68.27
STOCH RSI(14)
Overbought 88.65
MACD(12,26)
Bullish 13.17
ADX(14)
Weak Trend 19.07
UO(9)
Bearish 48.46
ROC(12)
Uptrend And Accelerating 9.57
WillR(14)
Neutral -38.95
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across 20 cities in India, offering laboratory services, radiology and imaging, cardiology, neurology, and gastroenterology services. In 2021, Vijaya Diagnostic Centre Limited went public with an IPO of Rs 1895.04 crore and its shares were listed on the BSE and NSE.
Listing Date
14 Sept, 2021(3 Years,
26 days)
Chairperson NameSura Surendranath Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
